Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390013
Status:
TERMINATED
Last Update Posted:
2017-07-31
First Post:
2006-10-18
Brief Title:
To Evaluate if the Medication Gabapentin Lessens Vulvar Pain
Sponsor:
Colleen Stockdale
Organization:
University of Iowa
Study Overview
Official Title:
Vulvar Pain Treatment Trial Using Gabapentin-placebo in a Cross-over Design Pilot Study
Status:
TERMINATED
Status Verified Date:
2017-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
poor recruitment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience
Detailed Description:
There is not a best treatment plan for vulvar pain including vulvodynia chronic vulvar pain and vulvar vestibulitis syndrome VVS chronic vulvar pain localized to the vaginal opening We propose that vulvodynia is a neuropathic pain pain that effects the nervous system as characterized by pain from stimuli that is not usually painful stimuli that would not usually be painful causing significant pain and burning pain Gabapentin has been shown to be effective in treating chronic pain
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RR00059 | OTHER | None | None |
| 200606748 | OTHER | University of Iowa | None |